<DOC>
	<DOCNO>NCT02785835</DOCNO>
	<brief_summary>Observational study . All HIV-infected patient diagnose hepatocellular carcinoma ( HCC ) , follow American Association Study Liver Diseases ( AASLD ) criterion , participant center include . Epidemiological , clinical laboratory data collect . The clinical epidemiological characteristic HCC case analyze . The efficacy outcomes modality HCC therapy assess . Mortality predictor also assess . In case infect hepatitis C virus ( HCV ) , impact HCV therapy outcome analyse .</brief_summary>
	<brief_title>Hepatocellular Carcinoma HIV-infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>HIV infection Diagnosis hepatocellular carcinoma accord American Association Study Liver Diseases ( AASLD ) criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>